This report provides market landscape, competitive landscape and market trends information the diabetes care devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
Scope of the report:
• Key segments covered include glucose monitoring devices (blood glucose test strips, blood glucose meters, lancets), and insulin delivery devices (insulin pens, insulin syringes, insulin pumps).
• Annualized global market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
• Qualitative analysis of key market drivers and restraints by each category within diabetes care devices market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Roche, LifeScan, Novo Nordisk, Eli Lilly, Bayer, and Medtronic.
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/
# # #
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.